39
Views
4
CrossRef citations to date
0
Altmetric
Review Article

Antidepressant-Induced Sexual Dysfunction: Review, Classification, and Suggestions for Treatment

Pages 177-189 | Received 03 Mar 1998, Accepted 13 Apr 1998, Published online: 03 Jul 2009

References

  • Montejo-González AL, Llorca G, Izquierdo JA, Ledesma A, Bousono M, Calcedo A, et al. SSRI-induced sexual dysfunction:, fluoxetineparoxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients. J Sex Marital Ther 1997; 23: 176–94
  • Zajecka J, Mitchell S, Fawcett J. Treatment-emergent changes in sexual function with selective serotonin reuptake inhibitors as measured with the Rush Sexual Inventory. Psychopharmacol Bull 1997; 33: 755–60
  • Monteiro WO, Norshirvani HF, Marks IM, Lelliott FT. Anorgasmia from clomipramine in obsessive-compulsive disorder: a controlled trial. Br J Psychiatry 1987; 151: 107–12
  • Masters WH, Johnson VE. Human sexual response. Little, Brown, Boston 1966
  • Harvey KV, Balon R. Clinical implications of antidepressant drug effects on sexual function. Ann Clin Psychiatry 1995; 7: 189–201
  • Crenshaw TL, Goldberg JP. Sexual pharmacology: drugs that affect sexual functioning. Norton, New York 1996
  • Riley AJ, Peet M, Wilson C. Sexual pharmacology. Oxford University Press, New York 1993
  • Schiavi RC, Segraves RT. The biology of sexual function. Psychiatr Clin North Am 1995; 18: 7–23
  • Segraves RT. Effects of psychotropic drugs on human erection and ejaculation. Arch Gen Psychiatry 1989; 46: 275–84
  • Melis MR, Argiolas A. Dopamine and sexual behavior. Neurosci Biobehav Rev 1995; 19: 19–38
  • American Psychiatric Association. Diagnostic and statistical manual of mental disorders.4th ed. American Psychiatric Association, Washington, DC 1994
  • Gitlin MJ. Psychotropic medications and their effects on sexual function:, diagnosisbiology, and treatment approaches. J Clin Psychiatry 1994; 55: 406–13
  • Kafka MP. Update on paraphilias and paraphilia-related disorders. Curr Affect Illness 1993; 12(6)5–13
  • Mathew RJ, Weinman ML. Sexual dysfunctions in depression. Arch Sex Behav 1982; 11: 323–8
  • Clayton AH, McGarvey EL, Clavet GJ, Piazza L. Comparison of sexual functioning in clinical and nonclinical populations using the Changes in Sexual Functioning Questionnaire (CSFQ). Psychopharmacol Bull 1997; 33: 747–53
  • Schreiner-Engel P, Schiavi RC. Lifetime psychopathology in individuals with low sexual desire. J Nerv Ment Dis 1986; 174: 646–51
  • Nathan S. The epidemiology of the DSM-III psychosexual dysfunctions. J Sex Marital Ther 1986; 12: 267–81
  • Segraves RT. Overview of sexual dysfunction complicating the treatment of depression. J Clin Psychiatry Monogr 1992; 10(2)4–10
  • Ashton AK, Hamer R, Rosen RC. Serotonin reuptake inhibitor-induced sexual dysfunction and its treatment: a large-scale retrospective study of 596 psychiatric outpatients. J Sex Marital Ther 1997; 23: 165–75
  • Crenshaw TL, Goldberg JP, Stern WC. Pharmacologic modification of psychosexual dysfunction. J Sex Marital Ther 1987; 13: 239–52
  • Modell JG, Katholi CR, Modell JD, DePalma RL. Comparative sexual side effects of, bupropionfluoxetine, paroxetine, and sertraline. Clin Pharmacol Ther 1997; 61: 476–87
  • Sullivan G. Increased libido in three men treated with trazodone. J Clin Psychiatry 1988; 49: 202–3
  • Gartrell N. Increased libido in women receiving trazodone. Am J Psychiatry 1986; 143: 781–2
  • Balon R. Sexual obsessions associated with fluoxetine [Letter]. J Clin Psychiatry 1994; 55: 496
  • Elmore JL, Quattlebaum JT. Female sexual stimulation during antidepressant treatment. Pharmacotherapy 1997; 17: 612–6
  • Michael A, Owen A. Venlafaxine-induced increased libido and spontaneous erections [Letter]. Br J Psychiatry 1997; 170: 193
  • Power-Smith P. Beneficial sexual side-effects from fluoxetine. Br J Psychiatry 1994; 164: 249–50
  • King VL, Jr, Horowitz IR. Vaginal anesthesia associated with fluoxetine use [Letter]. Am J Psychiatry 1993; 150: 984–5
  • Ellison JM, DeLuca P. Fluoxetine-induced genital anesthesia relieved by Ginkgo biloba extract [Letter]. J Clin Psychiatry 1998; 59: 199–200
  • Pescatori ES, Engelman JC, Davis G, Goldstein I. Priapism of the clitoris: a case report following trazodone use. J Urol 1993; 149: 1557–9
  • Levenson JL. Priapism associated with bupropion treatment [Letter]. Am J Psychiatry 1995; 152: 813
  • Berk M, Acton M. Citalopram-associated clitoral priapism: a case series. Int Clin Psychopharmacol 1997; 12: 121–2
  • Fossey MD, Hamner MB. Male sexual dysfunction induced by bupropion sustained release [Abstract]. New research program and abstracts of the 1994 annual meeting of the American Psychiatric Association. 1994. Philadelphia, Pennsylvania May, 1994; 216
  • Segraves RT, Segraves KB, Bubna CN. Sexual function in patients taking bupropion sustained release [Letter]. J Clin Psychiatry 1995; 56: 374
  • Neill JR. Penile anesthesia associated with fluoxetine use [Letter]. Am J Psychiatry 1991; 148: 1603
  • Smith DM, Levitte SS. Association of fluoxetine and return of sexual potency in three elderly men. J Clin Psychiatry 1993; 54: 317–9
  • Thompson JW, Jr, Ware MR, Blashfield RK. Psychotropic medication and priapism: a comprehensive review. J Clin Psychiatry 1990; 51: 430–3
  • Warner MD, Peabody CA, Whiteford HA, Hollister LE. Trazodone and priapism. J Clin Psychiatry 1987; 48: 244–5
  • Bertholon F, Krajewski Y, El Allali A. Adverse effects: priapism caused by paroxetine [In, French, with English, abstract]. Ann Med Psychol, (Paris) 1996; 154: 145–6
  • Mendelson WB, Franko T. Priapism with sertraline and lithium [Letter]. J Clin Psychopharmacol 1994; 14: 434–5
  • Yeragani VK, Gershon S. Priapism related to phenelzine therapy [Letter]. N Engl J Med 1987; 317: 117–8
  • Murray MJ, Hooberman D. Fluoxetine and prolonged erection [Letter]. Am J Psychiatry 1993; 150: 167–8
  • Harrison WM, Rabkin JG, Ehrhardt AA, Stewart JW, McGrath PJ, Ross D, et al. Effects of antidepressant medication on sexual function: a controlled study. J Clin Psychopharmacol 1986; 6: 144–9
  • Jani NN, Wise TN, Kass E, Sessler A. Trazodone and anorgasmia, [Letter]. Am J Psychiatry 1988; 145: 896
  • McLean JD, Forsythe RG, Kapkin IA. Unusual side effects of clomipramine associated with yawning. Can J Psychiatry 1983; 28: 569–70
  • Modell JG. Repeated observations of, yawning, clitoral, engorgement, and orgasm associated with fluoxetine administration, [Letter]. J Clin, Psychopharmacol 1989; 9: 63–5
  • Purcell P, Ghurye R. Trazodone and spontaneous orgasms in an elderly postmenopausal woman: a case report [Letter]. J Clin Psychopharmacol 1995; 15: 293–5
  • Lauerma H. A case of moclobemide-induced hyperorgasmia. Int Clin Psychopharmacol 1995; 10: 123–4
  • Grimes JB, Labbate LA. Spontaneous orgasm with the combined use of bupropion and sertraline [Letter]. Biol Psychiatry 1996; 40: 1184–5
  • Ellison JM. Exercise-induced orgasms associated with fluoxetine treatment of depression [Letter]. J Clin Psychiatry 1996; 57: 596–7
  • Dorevitch A, Davis H. Fluvoxamine-associated sexual dysfunction. Ann Pharmacother 1994; 28: 872–4
  • Schwarcz G. Case report of inhibition of ejaculation and retrograde ejaculation as side effects of amoxapine. Am J Psychiatry 1982; 139: 233–4
  • Morris PL. Fluoxetine and orgasmic sexual experiences. Int J Psychiatry Med 1991; 21: 379–82
  • García-Campayo J, Sanz-Carrillo C, Lobo A. Orgasmic sexual experiences as a side effect of fluoxetine: a case report. Acta Psychiatr Scand 1995; 91: 69–70
  • Ravsten DV, Smith NB, Thatcher GW. Spontaneous male orgasm in association with venlafaxine [Letter]. Am Fam Physician 1997; 55: 1561, 1564, 1574
  • Michael A, Ramana R. Nefazodone-induced spontaneous ejaculation [Letter]. Br J Psychiatry 1996; 169: 672–3
  • Benazzi F. Involuntary sperm emission with fluoxetine, [Letter]. Can J, Psychiatry 1995; 40: 431
  • Assalian P. Clomipramine in the treatment of premature ejaculation. J Sex Res 1988; 24: 213–5
  • Kara H, Aydin S, Yücel M, Agargün MY, Odabaŝ O, Yilmaz Y. The efficacy of fluoxetine in the treatment of premature ejaculation: a double-blind placebo controlled study. J Urol 1996; 156: 1631–2
  • Mendels J, Camera A, Sikes C. Sertraline treatment for premature ejaculation. J Clin Psychopharmacol 1995; 15: 341–6
  • Waldinger MD, Hengeveld MW, Zwinderman AH. Ejaculation-retarding properties of paroxetine in patients with primary premature ejaculation: a, double-blindrandomized, dose-response study. Br J Urol 1997; 79: 592–5
  • Ludovico GM, Corvasce A, Pagliarulo G, Cirillo-Marucco E, Marano A, Pagliarulo A. Paroxetine in the treatment of premature ejaculation. Br J Urol 1996; 77: 881–2
  • Aizenberg D, Zemishlany Z, Hermesh H, Karp L, Weizman A. Painful ejaculation associated with antidepressants in four patients. J Clin Psychiatry 1991; 52: 461–3
  • Reynolds CF, III, Frank E, Thase ME, Houck PR, Jennings JR, Howell JR, et al. Assessment of sexual function in, depressedimpotent, and healthy men: factor analysis of a Brief Sexual Function Questionnaire for men. Psychiatry Res 1988; 24: 231–50
  • Derogatis LP, Meliasarotos N. The DSFI: a multidimensional measure of sexual functioning. J Sex Marital Ther 1979; 5: 244–81
  • LoPiccolo J, Steger JC. The Sexual Interaction Inventory: a new instrument for assessment of sexual dysfunction. Arch Sex Behav 1974; 3: 585–95
  • Hudson WW, Harrison DF, Crosscup PC. A short-form scale to measure sexual discord in dyadic relationships. J Sex Res 1981; 17: 157–74
  • Rust J, Golombok S. The Golombok-Rust Inventory of Sexual Satisfaction (GRISS). Br J Clin Psychol 1985; 24: 63–4
  • Othmer E, Othmer SC. Evaluation of sexual dysfunction. J Clin Psychiatry 1987; 48: 191–3
  • Grimes JB, Labbate LA, Hines AH. Sexual dysfunction induced by the SSRIs lAbstract]. New research program and abstracts of the 1996 annual meeting of the American Psychiatric Association. 1996. New York May, 1996; 92–3
  • Rothschild AJ. Selective serotonin reuptake inhibitor-induced sexual dysfunction: efficacy of a drug holiday. Am J Psychiatry 1995; 152: 1514–6
  • Nemeth A, Arato M, Treuer T, Vandlik E. Treatment of flu-voxamine-induced anorgasmia with a partial drug holiday I Letter]. Am J Psychiatry 1996; 153: 1365
  • Physicians' desk reference.51st ed. Medical Economics, Montvale, New Jersey, 1998
  • Ashton AK, Rosen RC. Bupropion as an antidote for serotonin reuptake inhibitor-induced sexual dysfunction. J Clin Psychiatry 1998; 59: 112–5
  • Labbate LA, Pollack MH. Treatment of fluoxetine-induced sexual dysfunction with bupropion: a case report. Ann Clin Psychiatry 1994; 6: 13–5
  • Labbate LA, Grimes JB, Hines A, Pollack MH. Bupropion treatment of serotonin reuptake antidepressant-associated sexual dysfunction. Ann Clin Psychiatry 1997; 9: 241–5
  • Bodkin JA, Lasser RA, Wines JD, Jr, Gardner DM, Baldessa-Rini RJ. Combining serotonin reuptake inhibitors and bupropion in partial responders to antidepressant monotherapy. J Clin Psychiatry 1997; 58: 137–45
  • Van Putten T, Shaffer I. Delirium associated with bupropion [Letter]. J Clin Psychopharmacol 1990; 10: 234
  • Young SJ. Panic associated with combining fluoxetine and bupropion [Letter]. J Clin Psychiatry 1996; 57: 177–8
  • Balogh S, Hendricks SE, Rang J. Treatment of fluoxetine-induced anorgasmia with amantadine Letter. J Clin Psychiatry 1992; 53: 212–3
  • Balon R. Intermittent amantadine for fluoxetine-induced anorgasmia. J Sex Marital Ther 1996; 22: 290–2
  • Gitlin MJ. Treatment of sexual side effects with dopaminergic agents [Letter]. J Clin Psychiatry 1995; 56: 124
  • Bartlik BD, Kaplan P, Kaplan HS. Psychostimulants apparently reverse sexual dysfunction secondary to selective serotonin re-uptake inhibitors. J Sex Marital Ther 1995; 21: 264–71
  • Sullivan G, Lukoff D. Sexual side effects of antipsychotic medication: evaluation and interventions. Hosp Community Psychiatry 1990; 41: 1238–41
  • Vogt HJ, Brandl P, Kockott G, Schmitz JR, Wiegand MH, Schadrack J, et al. Double-blind, placebo-controlled safety and efficacy trial with yohimbine hydrochloride in the treatment of nonorganic erectile dysfunction. Int J Impot Res 1997; 9: 155–61
  • Hollander E, McCarley A. Yohimbine treatment of sexual side effects induced by serotonin reuptake blockers. J Clin Psychiatry 1992; 53: 207–9
  • Jacobsen FM. Fluoxetine-induced sexual dysfunction and an open trial of yohimbine. J Clin Psychiatry 1992; 53: 119–22
  • Price J, Grunhaus LJ. Treatment of clomipramine-induced anorgasmia with yohimbine: a case report. J Clin Psychiatry 1990; 51: 32–3
  • DeCastro RM. Reversal of MAOI-induced anorgasmia with cyproheptadine [Letter]. Am J Psychiatry 1985; 142: 783
  • Riley AJ, Riley EJ. Cyproheptadine and antidepressant-induced anorgasmia ILetter]. Br J Psychiatry 1986; 148: 217–8
  • Steele TE, Howell EF. Cyproheptadine for imipramine-induced anorgasmia [Letter]. J Clin Psychopharmacol 1986; 6: 326–7
  • Sovner R. Treatment of tricyclic antidepressant-induced orgasmic inhibition with cyproheptadine [Letter]. J Clin Psychopharmacol 1984; 4: 169
  • Arnott S, Nutt D. Successful treatment of fluvoxamine-induced anorgasmia by cyproheptadine. Br J Psychiatry 1994; 164: 838–9
  • Aizenberg D, Zemishlany Z, Weizman A. Cyproheptadine treatment of sexual dysfunction induced by serotonin reuptake inhibitors. Clin Neuropharmacol 1995; 18: 320–4
  • McCormick S, Olin J, Brotman AW. Reversal of fluoxetine-induced anorgasmia by cyproheptadine in two patients. J Clin Psychiatry 1990; 51: 383–4
  • Cohen AJ. Fluoxetine-induced yawning and anorgasmia reversed by cyproheptadine treatment [Letter]. J Clin Psychiatry 1992; 53: 174
  • Kahn DA. Possible toxic interaction between cyproheptadine and phenelzine [Letter]. Am J Psychiatry 1987; 144: 1242–3
  • Feder R. Reversal of antidepressant activity of fluoxetine by cyproheptadine in three patients. J Clin Psychiatry 1991; 52: 163–4
  • Katz RJ, Rosenthal M. Adverse interaction of cyproheptadine with serotonergic antidepressants [Letter]. J Clin Psychiatry 1994; 55: 314–5
  • Goldbloom DS, Kennedy SH. Adverse interaction of fluoxetine and cyproheptadine in two patients with bulimia nervosa. J Clin Psychiatry 1991; 52: 261–2
  • Reynolds RD. Sertraline-induced anorgasmia treated with intermittent nefazodone [Letter]. J Clin Psychiatry 1997; 58: 89
  • Nelson EB, Keck PE, Jr, McElroy SL. Resolution of fluoxetine-induced sexual dysfunction with the, 5-HT, antagonist granisetron, [Letter]. J Clin, Psychiatry 1997; 58: 496–7
  • Simon P, Bertrand J, Costentin J. 5-HT1A receptor blockade increases penile erections induced by indirect serotonin agonists. Neuroreport 1993; 5: 229–30
  • Norden MJ. Buspirone treatment of sexual dysfunction associated with selective serotonin re-uptake inhibitors. Depression 1994; 2: 109–12
  • Cohen AJ. Treatment of antidepressant-induced sexual dysfunction with Ginkgo biloba extract. Abstracts New research program and abstracts of the 1996 annual meeting of the American Psychiatric Association. 1996. New York May, 1996; 266
  • Rowin J, Lewis SL. Spontaneous bilateral subdural hematomas associated with chronic Ginkgo biloba ingestion. Neurology 1996; 46: 1775–6
  • Odawara M, Tamaoka A, Yamashita K. Ginkgo biloba [Letter]. Neurology 1997; 48: 789–90
  • Tyler VE. The honest herbal: a sensible guide to the use of herbs and related remedies. Pharmaceutical Products Press, New York, 1992
  • Choi HK, Seong DH, Rha KH. Clinical efficacy of Korean red ginseng for erectile dysfunction. Int J Impot Res 1995; 7: 181–6
  • Boolell M, Gepi-Attee S, Gingell JC, Allen MJ. Sildenafil, a novel effective oral therapy for male erectile dysfunction. Br J Urol 1996; 78: 257–61
  • Heaton JP, Morales A, Adams MA, Johnston B, El-Rashidy R. Recovery of erectile function by the oral administration of apomorphine. Urology 1995; 45: 200–6
  • Becker AJ, Stief CG, Machtens S, Schultheiss D, Hartmann U, Truss MC, et al. Oral phentolamine as treatment for erectile dysfunction. J Urol 1998; 159: 1214–6
  • Gardner EA, Johnston AJ. Bupropion—an antidepressant without sexual pathophysiological action. J Clin Psychophar-macol 1985; 5: 24–9
  • Walker PW, Cole JO, Gardner EA, Hughes AR, Johnston JA, Batey SR, et al. Improvement in fluoxetine-associated sexual dysfunction in patients switched to bupropion. J Clin Psychiatry 1993; 54: 459–65
  • Kavoussi RJ, Segraves RT, Hughes AR, Ascher JA, Johnston JA. Double-blind comparison of bupropion sustained release and sertraline in depressed outpatients. J Clin Psychiatry 1997; 58: 532–7
  • Feiger A, Kiev A, Shrivastava RK, Wisselink PG, Wilcox CS. Nefazodone versus sertraline in outpatients with major depression: focus on, efficacytolerability, and effects on sexual function and satisfaction. J Clin Psychiatry 1996; 57: 53–62, suppl 2
  • Philipp M, Kohnen R, Benkert O. A comparison study of moclobemide and doxepin in major depression with special reference to effects of sexual dysfunction. Int Clin Psychopharmacol 1993; 7: 149–53
  • Boyarski BK. Sexual side effects of mirtazapine in depression [Abstract]. New research program and abstracts of the 1998 annual meeting of the American Psychiatric Association. 1998. Toronto June, 1998; 72

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.